ByHeart, the next-generation infant nutrition company, proudly announces the appointment of Denice Torres to its Board of Directors. This strategic addition underscores ByHeart's commitment to advancing innovation, giving all parents confidence in feeding, and fostering meaningful growth within the sector. Torres brings a wealth of experience in biotech and healthcare industries, further solidifying ByHeart’s position as a pioneer in the field of infant nutrition.
"We were immediately drawn to Denice's commitment to driving meaningful change in the healthcare industry,” said Mia Funt & Ron Belldegrun, Co-Founders of ByHeart. “Her passion for doing better for babies and their parents with no-compromise nutrition, alongside her dedication to mentorship and building strong company cultures, aligns perfectly with our mission to pioneer the next generation of infant nutrition and support parents throughout their feeding journey. Denice’s strategic insight will be invaluable as we continue to make advancements and expand our presence within the space, while maintaining our unwavering commitment to unparalleled transparency, quality and innovation for parents."
As the former Chief Strategy and Business Transformation Officer and President of McNeil Consumer Healthcare at Johnson & Johnson, Torres brings over three decades of executive leadership in healthcare, consumer products, and life sciences. She joins ByHeart after being drawn to the company for its leadership, its commitment to innovation, and the opportunity to make a significant impact on families and the future of infant nutrition.
"I am honored to join ByHeart's Board of Directors," said Torres. “As a mother, I understand the challenges parents face when choosing the right baby formula. I admire ByHeart’s mission of transparency and providing parents peace of mind, ensuring they can trust that their children are receiving the best. The company’s commitment to owning the entire supply chain and doing the hard work to ensure only the highest quality and certified-clean ingredients for babies aligns perfectly with my values around quality and no-compromise solutions for the next generation.”
This appointment comes at a time of significant growth for ByHeart, which has quickly established itself as a leading innovator in infant nutrition, reaching the top 10% of the US Infant Formula Category in less than a year on the market.1 With ByHeart’s science-backed formula and complete control over its end-to-end manufacturing, Torres’ leadership will play a crucial role in guiding the company’s next chapter of strategic growth, where they will continue to redefine a stagnant industry and further raise the standards in infant nutrition.
For more information about ByHeart’s Whole Nutrition Infant Formula, please visit https://byheart.com.
About ByHeart
Founded in 2016, ByHeart is a next-generation infant nutrition company that was built from the ground up to obsessively innovate and improve nutrition on behalf of babies. As one of the only fully integrated, FDA-registered infant formula brands in the U.S., ByHeart is driven by nutritional excellence and uncompromising quality standards. With manufacturing facilities in Pennsylvania, Oregon, and Iowa, the company is committed to handpicking the finest certified-clean ingredients, controlling every step of R&D, and using a closest-to-breast-milk patented protein blend to provide parents with unmatched peace of mind and transparency for their babies. As a result, ByHeart is the only U.S.-made infant formula company to earn all three prestigious certifications from the Clean Label Project. For more information on ByHeart, visit https://byheart.com.
1Circana L13 Wks W.E. 10/6/24
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205112253/en/
Press Contact
SGPR (byheart@smallgirlspr.com)
